UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

16 Jan 2019

UCB and Amgen Receive Positive Vote From FDA Advisory Committee In Favor of Approval For EVENITY™ (Romosozumab) 

Read More
8 Jan 2019

EVENITY® (romosozumab) Receives Approval In Japan for the Treatment of Osteoporosis In Patients at High Risk of Fracture

Read More
8 Jan 2019

Transparency notification UCB SA/NV

Read More

Stay up-to-date on the latest news and information from UCB